User:Mr. Ibrahem/Lurasidone

Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth.

Common side effects include sleepiness, movement disorders, nausea, and diarrhea. Serious side effects may include the potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, angioedema, and high blood sugar levels. In older people with psychosis as a result of dementia, it may increase the risk of dying. Use during pregnancy is of unclear safety. How it works is not clear but is believed to involve effects on dopamine and serotonin in the brain.

Lurasidone was approved for medical use in the United States in 2010. A month supply in the United Kingdom costs the NHS about £91 as of 2019. In the United States this amount is about US$1,350 as of 2020. In 2019 generic versions were approved in the United States but will not be available until 2023. In 2017, it was the 274th most commonly prescribed medication in the United States, with more than one million prescriptions.